
Prof Alessandro Gozzetti
Prof Alessandro Gozzetti gained his medical degree in 1993 and hematology fellowship in 1997 from Bologna University, Italy and completed a PhD in Oncology in 2001. He worked as research fellow 3 years at the University of Chicago at the Molecular Cytogenetic
Cancer Center lab led by Dr Janet Rowley and Michelle Le Beau and discovered new translocations using fluorescence in situ hybridization in non-Hodgkin lymphomas, CLL and myeloma (Cancer Research, 2000)
He is Associate Professor of Hematology at the Division of Hematology of University of Siena since 2018. Prof. Gozzetti is Director of the Multiple Myeloma program at the University of Siena and Director of the Hematology Specialization School since 2020.
He participated in several multiple myeloma trials as PI and was in the writing committee in many of them. He led national research on CNS myeloma (Cancer 2012) and a multicenter phase 2 trial in Multiple Myeloma on Daratumumab as consolidation therapy in
patients MRD positive by next-generation flow that was recently published (DART4MM, Br J Hematol 2026).
His Areas of interest are: Multiple Myeloma; MRD, hematological molecular cytogenetics. He is one of the founders of the Multiple Myeloma Tuscan Group (RTM) and member of the International Myeloma Working Group since 2016.
He is Member of Italian Society of Hematology (SIE) and Italian Society of Experimental Hematology (SIES), European Hematology Association (EHA), International Myeloma Society (IMS).
He published as author or coauthor over 250 papers in peer reviewed Journals and over 200 abstracts and 3 book chapters.